nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
|
Spraggon, Lee |
|
2013 |
10 |
3 |
p. e139-e148 nvt p. |
artikel |
2 |
Antisense oligonucleotide based drugs: progress and challenges
|
Bennett, C. Frank |
|
2013 |
10 |
3 |
p. e105-e107 nvt p. |
artikel |
3 |
Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy
|
van Deutekom, Judith C. |
|
2013 |
10 |
3 |
p. e149-e156 nvt p. |
artikel |
4 |
Antisense therapies for cancer
|
MacLeod, A. Robert |
|
2013 |
10 |
3 |
p. e157-e163 nvt p. |
artikel |
5 |
Antisense therapies for cardiovascular/metabolic diseases
|
Geary, Richard S. |
|
2013 |
10 |
3 |
p. e165-e170 nvt p. |
artikel |
6 |
Clinical development of synthetic siRNA therapeutics
|
Thompson, James D. |
|
2013 |
10 |
3 |
p. e133-e138 nvt p. |
artikel |
7 |
Contents
|
|
|
2013 |
10 |
3 |
p. i- 1 p. |
artikel |
8 |
Natural antisense transcripts as therapeutic targets
|
Halley, Paul |
|
2013 |
10 |
3 |
p. e119-e125 nvt p. |
artikel |
9 |
RNA directed therapeutics: mechanisms and status
|
Crooke, Stanley T. |
|
2013 |
10 |
3 |
p. e109-e117 nvt p. |
artikel |
10 |
Therapeutic modulation of microRNAs
|
Chau, B. Nelson |
|
2013 |
10 |
3 |
p. e127-e132 nvt p. |
artikel |